Recently, the big news in our CLL universe is about Ibrutinib. You may have read about it in the Forbes article, The Wild Story Behind A Promising Experimental Cancer Drug, on WebMD blog, or in a local media article , e.g., New Drug to Help Battle Cancer.
For a drug likely to cost nearly $90k per year (my guess only) – insurance will likely look quite closely at who is receiving it. While CLL patients will greet the approval – it may still take a while for them to access the medicine. That is why getting involved in research studies is so important!!!!
For more Ibrutinib insights, check out these other related posts by Dr. Sharman.
April 22, 2013
Blood Cancers Update:
Source: Cure Magazine Newsletter
April 8, 2013